171 related articles for article (PubMed ID: 21695980)
1. [The apoptosis inhibitor survivin in transitional cell carcinoma of the urinary bladder].
Vol'pina OM; Zavalishina LE; Volkova TD; Akhidova EV; Koroev DO; Andreeva IuIu; Petrov AN; Frank GA
Arkh Patol; 2011; 73(2):8-10. PubMed ID: 21695980
[TBL] [Abstract][Full Text] [Related]
2. Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma.
Sun YW; Xuan Q; Shu QA; Wu SS; Chen H; Xiao J; Xiang P; Zhu YP; Wang FL; Zhao ST
Genet Mol Res; 2013 Apr; 12(2):1045-53. PubMed ID: 23613251
[TBL] [Abstract][Full Text] [Related]
3. Expression of survivin in squamous cell carcinoma and transitional cell carcinoma of the urinary bladder: a comparative immunohistochemical study.
Makboul R; Refaiy AE; Badary FA; Abdelkawi IF; Merseburger AS; Mohammed RA
Korean J Urol; 2015 Jan; 56(1):31-40. PubMed ID: 25598934
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic significance of survivin in the progression of bladder transitional cell cancer.
Wang Y; Zhu Z; Zeng F; Wang L; Wu Y; Xia W; Xing S
J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):444-7. PubMed ID: 17828507
[TBL] [Abstract][Full Text] [Related]
5. THE SIGNIFICANCE OF EPIDERMAL GROWTH FACTOR RECEPTOR AND SURVIVIN EXPRESSION IN BLADDER CANCER TISSUE AND URINE CYTOLOGY OF PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER.
Kehinde EO; Al-Maghrebi M; Anim JT; Kapila K; George SS; Al-Juwaiser A; Memon A
East Afr Med J; 2013 Jan; 90(1):19-27. PubMed ID: 26862626
[TBL] [Abstract][Full Text] [Related]
6. Survivin and MKI67 mRNA expression in bladder washings of patients with superficial urothelial cell carcinoma correlate with tumor stage and grade but do not predict tumor recurrence.
Schultz IJ; Kiemeney LA; Willems JL; Swinkels DW; Witjes JA; de Kok JB
Clin Chem; 2006 Jul; 52(7):1440-2. PubMed ID: 16798976
[No Abstract] [Full Text] [Related]
7. [Expression of Survivin in transitional cell carcinoma of urinary bladder and its clinical significance].
Xiao ZJ; Zheng S; Chen W; Zhang HF; Li CL; Gao YN
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1977-9. PubMed ID: 15730809
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 and survivin in superficial urothelial carcinoma of the bladder and correlation with intratumoural microvessel density.
Yildirim U; Erdem H; Kayikci A; Sahin AF; Uzunlar AK; Albayrak A
J Int Med Res; 2010; 38(5):1689-99. PubMed ID: 21309483
[TBL] [Abstract][Full Text] [Related]
9. Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma.
Kitamura H; Torigoe T; Hirohashi Y; Asanuma H; Inoue R; Nishida S; Tanaka T; Masumori N; Sato N; Tsukamoto T
Virchows Arch; 2013 Jan; 462(1):101-7. PubMed ID: 23179762
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of survivin expression in patients with urothelial carcinoma.
Chen HA; Su CM; Hsieh HY; Tung CL; Hsu CD; Wang YH; Shen CH
Dis Markers; 2014; 2014():574985. PubMed ID: 24648609
[TBL] [Abstract][Full Text] [Related]
11. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance].
He XF; Wen DG; Hou JQ; He J; Cen JN
Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744
[TBL] [Abstract][Full Text] [Related]
12. A diagnostic marker for superficial urothelial bladder carcinoma: lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression.
Kawaguchi M; Hara N; Bilim V; Koike H; Suzuki M; Kim TS; Gao N; Dong Y; Zhang S; Fujinawa Y; Yamamoto O; Ito H; Tomita Y; Naruse Y; Sakamaki A; Ishii Y; Tsuneyama K; Inoue M; Itoh J; Yasuda M; Sakata N; Jung CG; Kanazawa S; Akatsu H; Minato H; Nojima T; Asai K; Miura Y
BMC Cancer; 2016 Oct; 16(1):805. PubMed ID: 27756245
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of nuclear CSE1L in urinary bladder urothelial carcinomas.
Chang CC; Tai CJ; Su TC; Shen KH; Lin SH; Yeh CM; Yeh KT; Lin YM; Jiang MC
Ann Diagn Pathol; 2012 Oct; 16(5):362-8. PubMed ID: 22476051
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 cases.
Compérat E; Camparo P; Haus R; Chartier-Kastler E; Bart S; Delcourt A; Houlgatte A; François R; Capron F; Vieillefond A
Virchows Arch; 2006 Mar; 448(3):319-24. PubMed ID: 16283378
[TBL] [Abstract][Full Text] [Related]
15. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
[TBL] [Abstract][Full Text] [Related]
16. Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder.
Ku JH; Kwak C; Lee HS; Park HK; Lee E; Lee SE
J Urol; 2004 Feb; 171(2 Pt 1):631-5. PubMed ID: 14713775
[TBL] [Abstract][Full Text] [Related]
17. Survivin protein expression positively correlated with proliferative activity of cancer cells in bladder cancer.
Wu Y; Wang G; Wei J; Wen X
Indian J Med Sci; 2005 Jun; 59(6):235-42. PubMed ID: 15988093
[TBL] [Abstract][Full Text] [Related]
18. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
King ED; Matteson J; Jacobs SC; Kyprianou N
J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878
[TBL] [Abstract][Full Text] [Related]
19. Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder.
Yin W; Chen N; Zhang Y; Zeng H; Chen X; He Y; Wang X; Zhou Q
Mod Pathol; 2006 Nov; 19(11):1487-97. PubMed ID: 16892011
[TBL] [Abstract][Full Text] [Related]
20. The relationship between the expression of E-cadherin and tumor recurrence and progression in high-grade stage T1 bladder urothelial carcinoma.
Erdemir F; Ozcan F; Kilicaslan I; Parlaktas BS; Uluocak N; Gokce O
Int Urol Nephrol; 2007; 39(4):1031-7. PubMed ID: 17340210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
